MA51913A - Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire - Google Patents
Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaireInfo
- Publication number
- MA51913A MA51913A MA051913A MA51913A MA51913A MA 51913 A MA51913 A MA 51913A MA 051913 A MA051913 A MA 051913A MA 51913 A MA51913 A MA 51913A MA 51913 A MA51913 A MA 51913A
- Authority
- MA
- Morocco
- Prior art keywords
- granular composition
- improving
- producing
- elution property
- granular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018029093 | 2018-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51913A true MA51913A (fr) | 2020-12-30 |
Family
ID=67687749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051913A MA51913A (fr) | 2018-02-21 | 2019-02-20 | Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20200397700A1 (fr) |
| EP (1) | EP3756670A4 (fr) |
| JP (2) | JP7430629B2 (fr) |
| KR (1) | KR20200123447A (fr) |
| CN (1) | CN112055591A (fr) |
| AR (1) | AR114399A1 (fr) |
| AU (1) | AU2019225516A1 (fr) |
| BR (1) | BR112020016230A2 (fr) |
| CA (1) | CA3091584A1 (fr) |
| CL (1) | CL2020002129A1 (fr) |
| CO (1) | CO2020011034A2 (fr) |
| EC (1) | ECSP20057951A (fr) |
| IL (1) | IL276732A (fr) |
| MA (1) | MA51913A (fr) |
| MX (1) | MX2020008695A (fr) |
| PE (1) | PE20210448A1 (fr) |
| PH (1) | PH12020551285A1 (fr) |
| RU (1) | RU2020130411A (fr) |
| SG (1) | SG11202007967YA (fr) |
| TW (1) | TW201936175A (fr) |
| WO (1) | WO2019163822A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4048235A1 (fr) * | 2019-10-23 | 2022-08-31 | Actelion Pharmaceuticals Ltd | Composition pharmaceutique comprenant du sélexipag |
| WO2021206159A1 (fr) * | 2020-04-10 | 2021-10-14 | 日本新薬株式会社 | Préparation solide et son procédé de fabrication |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2654197B2 (ja) * | 1989-09-25 | 1997-09-17 | 三菱電機株式会社 | スターリングエンジンの圧縮機駆動装置 |
| WO2002024168A1 (fr) * | 2000-09-25 | 2002-03-28 | Nippon Shinyaku Co., Ltd. | Procede de production d'une dispersion solide medicinale |
| TWI316055B (fr) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| ES2312741T3 (es) * | 2003-05-06 | 2009-03-01 | Gumlink A/S | Procedimiento para producir granulos de goma de mascar y granulos de goma comprimidos, y un equipo para granular goma de mascar. |
| GB0423103D0 (en) * | 2004-10-19 | 2004-11-17 | Boots Healthcare Int Ltd | Therapeutic agents |
| PT2447254T (pt) * | 2009-06-26 | 2018-01-04 | Nippon Shinyaku Co Ltd | Cristais |
| UA124002C2 (uk) | 2015-12-02 | 2021-07-07 | Ніппон Сіняку Ко., Лтд. | Твердий препарат, що містить 2-{4-[n-(5,6- дифенілпіразин-2-іл)-n-ізопропіламіно]бутилокси}-n-(метилсульфоніл)ацетамід |
| WO2017121806A1 (fr) * | 2016-01-15 | 2017-07-20 | Sandoz Ag | Composition pharmaceutique de selexipag |
-
2019
- 2019-02-20 CA CA3091584A patent/CA3091584A1/fr active Pending
- 2019-02-20 EP EP19756715.9A patent/EP3756670A4/fr active Pending
- 2019-02-20 AU AU2019225516A patent/AU2019225516A1/en active Pending
- 2019-02-20 JP JP2020500991A patent/JP7430629B2/ja active Active
- 2019-02-20 AR ARP190100423A patent/AR114399A1/es unknown
- 2019-02-20 BR BR112020016230-2A patent/BR112020016230A2/pt unknown
- 2019-02-20 SG SG11202007967YA patent/SG11202007967YA/en unknown
- 2019-02-20 KR KR1020207026724A patent/KR20200123447A/ko not_active Application Discontinuation
- 2019-02-20 RU RU2020130411A patent/RU2020130411A/ru unknown
- 2019-02-20 MA MA051913A patent/MA51913A/fr unknown
- 2019-02-20 TW TW108105520A patent/TW201936175A/zh unknown
- 2019-02-20 PE PE2020001259A patent/PE20210448A1/es unknown
- 2019-02-20 MX MX2020008695A patent/MX2020008695A/es unknown
- 2019-02-20 US US16/971,355 patent/US20200397700A1/en active Pending
- 2019-02-20 WO PCT/JP2019/006317 patent/WO2019163822A1/fr unknown
- 2019-02-20 CN CN201980014530.2A patent/CN112055591A/zh active Pending
-
2020
- 2020-08-16 IL IL276732A patent/IL276732A/en unknown
- 2020-08-18 CL CL2020002129A patent/CL2020002129A1/es unknown
- 2020-08-20 PH PH12020551285A patent/PH12020551285A1/en unknown
- 2020-09-03 CO CONC2020/0011034A patent/CO2020011034A2/es unknown
- 2020-09-17 EC ECSENADI202057951A patent/ECSP20057951A/es unknown
-
2023
- 2023-09-26 JP JP2023163205A patent/JP2023182650A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL276732A (en) | 2020-09-30 |
| JPWO2019163822A1 (ja) | 2021-02-04 |
| TW201936175A (zh) | 2019-09-16 |
| CL2020002129A1 (es) | 2021-02-05 |
| JP7430629B2 (ja) | 2024-02-13 |
| AU2019225516A1 (en) | 2020-10-08 |
| MX2020008695A (es) | 2020-09-25 |
| PE20210448A1 (es) | 2021-03-08 |
| PH12020551285A1 (en) | 2021-05-31 |
| CO2020011034A2 (es) | 2020-12-10 |
| SG11202007967YA (en) | 2020-09-29 |
| CN112055591A (zh) | 2020-12-08 |
| BR112020016230A2 (pt) | 2020-12-08 |
| JP2023182650A (ja) | 2023-12-26 |
| EP3756670A1 (fr) | 2020-12-30 |
| US20200397700A1 (en) | 2020-12-24 |
| KR20200123447A (ko) | 2020-10-29 |
| ECSP20057951A (es) | 2020-10-30 |
| RU2020130411A3 (fr) | 2022-03-21 |
| CA3091584A1 (fr) | 2019-08-29 |
| AR114399A1 (es) | 2020-09-02 |
| WO2019163822A1 (fr) | 2019-08-29 |
| EP3756670A4 (fr) | 2021-11-03 |
| RU2020130411A (ru) | 2022-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201908597B (en) | Process for the production of a nanocellulose material technical field | |
| MA42836A (fr) | Composition d'élastomère thermoplastique et son procédé de production | |
| MA48798A (fr) | Procédé de production d'ozanimod | |
| MA48723A (fr) | Procédé de production d'anticorps multispécifiques | |
| MA53673A (fr) | Procédé de production d'un dérivé de 4-méthoxy pyrrole | |
| MA51114A (fr) | Procédé de production d'une compositions de lymphocytes t modifiés | |
| MA50169A (fr) | Procédé de production d'un électrocatalyseur | |
| FR3038894B1 (fr) | Procede de fabrication d'aluminates de calcium | |
| MA50647A (fr) | Procédé de régulation d'un puits | |
| PT3320017T (pt) | Processo para a produção de tereftalato de polietileno modificado com glicol a partir de matérias-primas recicladas | |
| PL3466903T3 (pl) | Zestaw do wytwarzania wyrobu ogniotrwałego, sposób wytwarzania wyrobu ogniotrwałego, wyrób ogniotrwały oraz zastosowanie surowca syntetycznego | |
| MA51913A (fr) | Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire | |
| IL287991A (en) | Granules of polyhalite, potash and ammonium sulfate and a pressing process to create them | |
| MA52755A (fr) | Procédé d'enrobage d'engrais | |
| PL3838381T3 (pl) | Sposób wytwarzania tiosiarczanu amonu | |
| IL279845A (en) | Hydroxypropyl beta-cyclodextrin and a process for its preparation | |
| MA55284A (fr) | Procédés de production de compositions d'anticorps anti-tnf | |
| MA50859A (fr) | Procédé pour la production d'une composition de lymphocytes t | |
| MA55127A (fr) | Procédé de production d'alcanones plus élevées, de préférence 6-undécanones, et leurs dérivés | |
| SI3863685T1 (sl) | Postopek za proizvodnjo generatorja radija-228 z visoko vsebnostjo | |
| FR3055779B1 (fr) | Installation de production de composition comprenant des gouttes et procede de production associe | |
| MA50983A (fr) | Procédé pour la fabrication d'un disque composite | |
| PL3652131T3 (pl) | Powlekane polimocznikiem i poliuretanem cząstki nawozu zawierającego mocznik oraz sposób ich wytwarzania | |
| IL289971A (en) | Improved methods for the production of plants | |
| MA55283A (fr) | Procédés de production de compositions d'anticorps anti-tnf |